Friday, May 7, 2021
Home Tags Pharma

Pharma Related News

mescaline

XPhyto: Is mescaline the next big mood-modifying medicine?

Mescaline has the potential to be the next frontier in the psychedelics renaissance and represents an unprecedented opportunity to innovate a notable advancement in...
Those with prior COVID-19 infection have boosted immune response

Those with prior COVID-19 infection have boosted immune response

A new study has shown that people who have previously contracted COVID-19 have significantly higher T cell and antibody responses following a single dose...
Two trials for COVID-19 treatments launched in the UK

Two trials for COVID-19 treatments launched in the UK

The UK has launched two trials that will test the efficacy of treatments which prevent people from catching COVID-19. The PROTECT-V trial, run by the...

Vektor Pharma: leaders in thin film drug formulations

Vektor Pharma TF GmbH and its team have been leaders in the design, testing, and manufacture of thin film drug formulations. Vektor Pharma TF GmbH ...
Oxford vaccine data suggests it reduces COVID-19 transmission

Oxford vaccine data suggests it reduces COVID-19 transmission

New data on the Oxford/AstraZeneca vaccine has suggested that it may have a substantial impact on transmission of COVID-19. Analyses of PCR positive swabs from...
Global Ebola vaccine stockpile now established

Global Ebola vaccine stockpile now established

A global stockpile of Ebola vaccines has now been established by four of the leading health and humanitarian organisations. Led by the International Coordinating Group...
Moderna COVID-19 vaccine receives approval in UK

Moderna COVID-19 vaccine receives approval in UK

The British Government has now authorised the Moderna COVID-19 vaccine for use. The Moderna COVID-19 vaccine has become the third in Britain to gain authorisation...
COVID-19 immunity could last eight months, says research

COVID-19 immunity could last eight months, says research

New research has suggested that immunity to COVID-19 could last for up to eight months following infection. The findings, which were based on blood samples...
Lifesaving COVID-19 treatments for NHS patients

Lifesaving COVID-19 treatments for NHS patients

Patients in intensive care units across the UK will be receiving potentially lifesaving treatments for COVID-19. The government-funded REMAP-CAP clinical trial has shown that the...
WHO lists Pfizer/BioNTech COVID-19 vaccine for emergency use

WHO lists Pfizer/BioNTech COVID-19 vaccine for emergency use

As more countries across the globe begin rolling out their mass COVID-19 vaccination programmes, the World Health Organization (WHO) has now listed the Pfizer/BioNTech...
New pathway for approval of medicines in the UK

New pathway for approval of medicines in the UK

A new pathway for the approval of medicines in the UK has opened, aiming to bring closer collaboration between authorities and bodies and helping...
Oxford University COVID-19 vaccine roll out begins

Oxford University COVID-19 vaccine roll out begins

The first person in the UK has now received the Oxford University and AstraZeneca COVID-19 vaccine, which has begun its NHS roll out today. The...
European Commission concludes Novavax talks for COVID-19 vaccine

European Commission concludes Novavax talks for COVID-19 vaccine

The European Commission has concluded its talks with pharmaceutical company Novavax regarding the purchase of its potential COVID-19 vaccine. The European Commission and Novavax envisaged...
Clinical trials for another COVID-19 vaccine begin in UK

Clinical trials for another COVID-19 vaccine begin in UK

Early Phase I and Phase II clinical trials have started in the UK for the Valneva COVID-19 vaccine, which is to be tested on...
Pritelivir phase III clinical trials for HSV immunocompromised patients

Pritelivir Phase III clinical trials for HSV immunocompromised patients

The medicine Pritelivir is to enter Phase III clinical trials for the treatment of immunocompromised patients who have acyclovir-resistant mucocutaneous herpes simplex virus (HSV)...
AstraZeneca to test component of Russia’s Sputnik V vaccine

AstraZeneca to test component of Russia’s Sputnik V vaccine

AstraZeneca will be testing a component of Russia’s Sputnik V COVID-19 vaccine in clinical trials of its own vaccine against the virus. Following the preliminary...
Chemotherapy-free treatment for Chronic Lymphocytic Leukaemia patients

Chemotherapy-free treatment for Chronic Lymphocytic Leukaemia patients

For the first time, patients in Scotland with previously untreated Chronic Lymphocytic Leukaemia will be able to access chemotherapy-free treatment. The Scottish Medicines Consortium has...
COVID-19 Oxford vaccine found safe and effective in Phase III trial

COVID-19 Oxford vaccine found safe and effective in Phase III trial

The first full results from the Phase III Oxford COVID-19 vaccine have found it to be safe and effective to protect against the virus. The...
First ever patient to receive COVID-19 vaccination in the UK

First ever patient to receive COVID-19 vaccination in the UK

Today marks a landmark moment for the United Kingdom as the first NHS patient has received the Pfizer/BioNTech COVID-19 vaccine. The biggest vaccination campaign in...
Clinical trial investigates COVID-19 protection for health professionals

Clinical trial investigates COVID-19 protection for health professionals

Healthcare professionals in the UK will be taking part in a clinical trial to test the efficacy of Carragelose nasal spray for COVID-19 protection. To...

Health Special Reports

Health eBooks

Health Partners

Pin It on Pinterest